CMT Research Foundation invests in research project to develop treatments for CMTs
The rare, peripheral neuropathy disease affects nearly three million people globally
Read More
Tag: CMT1A
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
- eXmoor Pharma and UCL establish strategic cell and gene therapy collaboration
- Miranda Dini launches GOLD amid industry shifts
